Found: 46
Select item for more details and to access through your institution.
Mesenchymal stem cell secretome and extracellular vesicles for neurodegenerative diseases: Risk-benefit profile and next steps for the market access.
- Published in:
- Bioactive Materials, 2023, v. 29, p. 16, doi. 10.1016/j.bioactmat.2023.06.013
- By:
- Publication type:
- Article
Il costo a carico dei pazienti del percorso per eleggibilità ai farmaci PCSK9 e follow-up di un anno: i risultati dello Studio PRIOR.
- Published in:
- Global & Regional Health Technology Assessment, 2022, v. 9, n. 1, p. 73, doi. 10.33393/grhta.2022.2415
- By:
- Publication type:
- Article
Il bisogno insoddisfatto: definizioni, evidenze di letteratura e implicazioni per l'HTA.
- Published in:
- Global & Regional Health Technology Assessment, 2023, v. 10, n. 1, p. 70, doi. 10.33393/grhta.2023.2624
- By:
- Publication type:
- Article
Regolazione del prezzo e rimborso dei farmaci: comparatori, endpoint e ruolo della costo-efficacia.
- Published in:
- Global & Regional Health Technology Assessment, 2022, v. 9, n. 1, p. 99, doi. 10.33393/grhta.2022.2475
- By:
- Publication type:
- Article
Prezzo e rimborso dei farmaci in caso di estensione delle indicazioni: i risultati di una survey sui soci di ISPOR Italy Rome Chapter.
- Published in:
- Global & Regional Health Technology Assessment, 2023, v. 10, n. 1, p. 40, doi. 10.33393/grhta.2023.2562
- By:
- Publication type:
- Article
Price and reimbursement for orphan medicines and managed entry agreements: does Italy need a framework?
- Published in:
- Global & Regional Health Technology Assessment, 2021, v. 8, n. 1, p. 114, doi. 10.33393/grhta.2021.2278
- By:
- Publication type:
- Article
Preparation of intravenous chemotherapy bags: evaluation of a dose banding approach in an Italian oncology hospital.
- Published in:
- Global & Regional Health Technology Assessment, 2021, v. 8, n. 1, p. 29, doi. 10.33393/grhta.2021.2202
- By:
- Publication type:
- Article
Il futuro dei Fondi per Farmaci Innovativi: risultati di uno studio basato su Delphi panel.
- Published in:
- Global & Regional Health Technology Assessment, 2021, v. 8, n. 1, p. 22, doi. 10.33393/grhta.2021.2219
- By:
- Publication type:
- Article
L'impatto della cross-copertura di dupilumab sulla spesa a carico del Servizio Sanitario Nazionale.
- Published in:
- Global & Regional Health Technology Assessment, 2020, v. 7, n. 1, p. 33, doi. 10.33393/grhta.2020.2139
- By:
- Publication type:
- Article
Management of patients eligible for proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: economic impact and reform proposals.
- Published in:
- Global & Regional Health Technology Assessment, 2019, v. 2019, p. 1, doi. 10.1177/2284240319861375
- By:
- Publication type:
- Article
CAR T-Cell Therapies in Italy: Patient Access Barriers and Recommendations for Health System Solutions.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.915342
- By:
- Publication type:
- Article
EQ-5D-5L Population Norms for Italy.
- Published in:
- Applied Health Economics & Health Policy, 2023, v. 21, n. 2, p. 289, doi. 10.1007/s40258-022-00772-7
- By:
- Publication type:
- Article
Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates.
- Published in:
- Applied Health Economics & Health Policy, 2018, v. 16, n. 6, p. 803, doi. 10.1007/s40258-018-0419-1
- By:
- Publication type:
- Article
How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy?
- Published in:
- BMC Health Services Research, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12913-023-09494-5
- By:
- Publication type:
- Article
How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy?
- Published in:
- BMC Health Services Research, 2023, v. 23, p. 1, doi. 10.1186/s12913-023-09494-5
- By:
- Publication type:
- Article
A qualitative analysis and development of a conceptual model assessing financial toxicity in cancer patients accessing the universal healthcare system.
- Published in:
- 2021
- By:
- Publication type:
- journal article
New funding arrangements in the Italian National Health Service.
- Published in:
- International Journal of Health Planning & Management, 2001, v. 16, n. 4, p. 347, doi. 10.1002/hpm.641
- By:
- Publication type:
- Article
The assessment of new drugs for asthma and COPD: a Delphi study examining the perspectives of Italian payers and clinicians.
- Published in:
- Multidisciplinary Respiratory Medicine, 2016, v. 11, p. 1, doi. 10.1186/s40248-016-0038-3
- By:
- Publication type:
- Article
The simultaneous effects of pharmaceutical policies from payers' and patients' perspectives: Italy as a case study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The impact of generic reference pricing in Italy, a decade on.
- Published in:
- European Journal of Health Economics, 2013, v. 14, n. 6, p. 959, doi. 10.1007/s10198-012-0442-3
- By:
- Publication type:
- Article
Unlocking the potential of established products: toward new incentives rewarding innovation in Europe.
- Published in:
- Journal of Market Access & Health Policy, 2017, v. 5, n. 1, p. N.PAG, doi. 10.1080/20016689.2017.1298190
- By:
- Publication type:
- Article
Do France, Germany, and Italy agree on the added therapeutic value of medicines?
- Published in:
- International Journal of Technology Assessment in Health Care, 2023, v. 39, n. 1, p. 1, doi. 10.1017/S026646232300048X
- By:
- Publication type:
- Article
Facilitating More Efficient Negotiations for Innovative Therapies: A Value-Based Negotiation Framework – Corrigendum.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Facilitating [corrected] More Efficient Negotiations for Innovative Therapies: A Value-Based Negotiation Framework.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Facilitating More Efficient Negotiations for Innovative Therapies: A Value-Based Negotiation Framework – Corrigendum.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Facilitating More Efficient Negotiations for Innovative Therapies: A Value-Based Negotiation Framework.
- Published in:
- International Journal of Technology Assessment in Health Care, 2021, v. 38, n. 1, p. 1, doi. 10.1017/S0266462322000095
- By:
- Publication type:
- Article
PP70 Health Technology Assessment Evaluations Of Combination Drugs: The Italian Case Study.
- Published in:
- 2018
- By:
- Publication type:
- Abstract
PP40 HTA Evaluations Of Combination Drugs: Positive Reimbursement Solutions.
- Published in:
- 2018
- By:
- Publication type:
- Abstract
OP19 Unlocking The Potential Of Established Products: Need For Incentives.
- Published in:
- 2017
- By:
- Publication type:
- Abstract
Variables affecting pricing of orphan drugs: the Italian case.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The Last Decade of Italian Pharmaceutical Policy: Instability or Consolidation?
- Published in:
- PharmacoEconomics, 2008, v. 26, n. 1, p. 5, doi. 10.2165/00019053-200826010-00002
- By:
- Publication type:
- Article
Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side Effects.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 4, p. 303, doi. 10.1007/s40261-021-01000-1
- By:
- Publication type:
- Article
Content validity of the EQ-HWB and EQ-HWB-S in a sample of Italian patients, informal caregivers and members of the general public.
- Published in:
- Journal of Patient-Reported Outcomes, 2024, v. 8, n. 1, p. 1, doi. 10.1186/s41687-024-00706-y
- By:
- Publication type:
- Article
Corrigendum: The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in Italy.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in Italy.
- Published in:
- Frontiers in Pharmacology, 2018, p. N.PAG, doi. 10.3389/fphar.2018.01069
- By:
- Publication type:
- Article
The role of health technology assessment bodies in shaping drug development.
- Published in:
- Drug Design, Development & Therapy, 2014, v. 8, p. 2273, doi. 10.2147/DDDT.S49935
- By:
- Publication type:
- Article
From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy.
- Published in:
- PharmacoEconomics - Open, 2024, v. 8, n. 2, p. 251, doi. 10.1007/s41669-023-00467-2
- By:
- Publication type:
- Article
Shortage of plasma-derived medicinal products: what is next? narrative literature review on its causes and counteracting policies in Italy.
- Published in:
- Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1375891
- By:
- Publication type:
- Article
Current Pipelines for Neglected Diseases.
- Published in:
- PLoS Neglected Tropical Diseases, 2014, v. 8, n. 9, p. 1, doi. 10.1371/journal.pntd.0003092
- By:
- Publication type:
- Article
Current Pipelines for Neglected Diseases.
- Published in:
- PLoS Neglected Tropical Diseases, 2014, v. 8, n. 9, p. 1, doi. 10.1371/journal.pntd.0003092
- By:
- Publication type:
- Article
La riduzione del dosaggio giornaliero di efavirenz nella terapia antiretrovirale: impatto sul budget nell'Azienda Ospedaliera Universitaria Integrata di Verona.
- Published in:
- Infezioni in Medicina, 2014, v. 22, n. 2, p. 118
- By:
- Publication type:
- Article
The economic impact of compassionate use of medicines.
- Published in:
- BMC Health Services Research, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12913-021-07255-w
- By:
- Publication type:
- Article
The economic impact of compassionate use of medicines.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Health care costs of influenza-related episodes in high income countries: A systematic review.
- Published in:
- PLoS ONE, 2018, v. 13, n. 9, p. 1, doi. 10.1371/journal.pone.0202787
- By:
- Publication type:
- Article
Istituti di Health Technology Assessment e portatori di interesse.
- Published in:
- Giornale Italiano di Health Technology Assessment, 2012, v. 5, n. 1, p. 5, doi. 10.1007/BF03324824
- By:
- Publication type:
- Article
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study.
- Published in:
- BMC Health Services Research, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12913-023-10443-5
- By:
- Publication type:
- Article